Bimatoprost Solution/ Drops
Product Images NDC 70069-403

7 FDA label images from Somerset Therapeutics, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bimatoprost (NDC 70069-403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 01

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 01
Chemical structure of the active ingredient Bimatoprost, showing its molecular framework including hydroxyl groups, an amide linkage, and a phenyl ring.*
FDA Label Image

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 02

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 02
Label for Bimatoprost 0.03% Ophthalmic Solution, 2.5 mL, manufactured for Somerset Therapeutics, LLC. It includes the active ingredient concentration, preservative benzalkonium chloride 0.05 mg/mL, usage instructions indicating one drop daily in the evening, storage conditions (2-25°C), and a barcode. The label specifies Rx only and indicates for ophthalmic use only.*
FDA Label Image

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 03

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 03
Label for Bimatoprost Ophthalmic Solution 0.03% (0.3 mg/mL) sterile eye drops, 2.5 mL, manufactured for Somerset Therapeutics LLC. Includes active and inactive ingredients, storage instructions, usage note, and manufacturer contact details. The label features a barcode, dosage form, and a graphic of an eye.*
FDA Label Image

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 04

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 04
Bimatoprost 0.03% Ophthalmic Solution label showing active ingredient Bimatoprost 0.3 mg/mL and preservative benzalkonium chloride 0.05 mg/mL. The label indicates the solution is for ophthalmic use, supplied in a 5 mL container, manufactured for Somerset Therapeutics, LLC. Includes storage instructions and a barcode.*
FDA Label Image

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 05

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 05
Label for Bimatoprost Ophthalmic Solution 0.03% (0.3 mg/mL) sterile eye drops in a 5 mL bottle by Somerset Therapeutics LLC. The label includes active and inactive ingredients, usual dosage instructions for one drop in the affected eye once daily in the evening, storage temperature range (2-25°C), and manufacturing details indicating it is made in India.*
FDA Label Image

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 06

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 06
Label for Bimatoprost Ophthalmic Solution 0.03% (0.3 mg/mL) in a 7.5 mL bottle. The label states it is for use in the eyes only, contains benzalkonium chloride preservative, and is manufactured for Somerset Therapeutics, LLC, Hollywood, FL. The product is labeled Rx only.*
FDA Label Image

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 07

3d7d24cc 76a8 48d2 9c86 A7470bb1ffac 07
Label for Bimatoprost Ophthalmic Solution 0.03% sterile eye drops in a 7.5 mL bottle. Manufactured for Somerset Therapeutics LLC. Active ingredient concentration is 0.3 mg/mL with benzalkonium chloride preservative. Label includes usage instructions for ophthalmic use only and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.